Prenatal interventions to prevent bronchopulmonary dysplasia in animal models: a systematic review

References

• Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371:75–84
   PubMed Web of Science ®Google Scholar
• Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008;371:261–9
   PubMed Web of Science ®Google Scholar
• Bancalari E, Claure N. Definitions and diagnostic criteria for bronchopulmonary dysplasia. Semin Perinatol 2006;30:164–70
   PubMed Web of Science ®Google Scholar
• Merritt TA, Deming DD, Boynton BR. The ‘new’ bronchopulmonary dysplasia: challenges and commentary. Semin Fetal Neonatal Med 2009;14:345–57
   PubMed Web of Science ®Google Scholar
• Doyle LW, Ford G, Davis N. Health and hospitalistions after discharge in extremely low birth weight infants. Semin Neonatol 2003;8:137–45
   PubMedGoogle Scholar
• Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007;357:1946–55
   PubMed Web of Science ®Google Scholar
• Ehrenkranz RA, Walsh MC, Vohr BR, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005;116:1353–60
   PubMed Web of Science ®Google Scholar
• Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723–9
   PubMedGoogle Scholar
• Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999;46:641–3
   PubMed Web of Science ®Google Scholar
• Levesque BM, Kalish LA, LaPierre J, et al. Impact of implementing 5 potentially better respiratory practices on neonatal outcomes and costs. Pediatrics 2011;128:e218–26
   PubMed Web of Science ®Google Scholar
• Speer CP. Pulmonary inflammation and bronchopulmonary dysplasia. J Perinatol 2006;26:S57–62. discussion S63-4
   PubMed Web of Science ®Google Scholar
• Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515–25
   PubMed Web of Science ®Google Scholar
• Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995;173:254–62
   PubMed Web of Science ®Google Scholar
• Liggins GC. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 1969;45:515–23
   PubMed Web of Science ®Google Scholar
• Brownfoot FC, Gagliardi DI, Bain E, et al. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2013;8:CD006764
   PubMed Web of Science ®Google Scholar
• Braun T, Challis JR, Newnham JP, Sloboda DM. Early-life glucocorticoid exposure: the hypothalamic-pituitary-adrenal axis, placental function, and long-term disease risk. Endocr Rev 2013;34:885–916
   PubMed Web of Science ®Google Scholar
• Hilgendorff A, Reiss I, Ehrhardt H, et al. Chronic lung disease in the preterm infant. Lessons learned from animal models. Am J Respir Cell Mol Biol 2014;50:233–45
   PubMed Web of Science ®Google Scholar
• Berger J, Bhandari V. Animal models of bronchopulmonary dysplasia. The term mouse models. Am J Physiol Lung Cell Mol Physiol 2014; 307:L936–47
   Web of Science ®Google Scholar
• O'Reilly M, Thebaud B. Animal models of bronchopulmonary dysplasia. The term rat models. Am J Physiol Lung Cell Mol Physiol 2014; 307:L948–58
   Web of Science ®Google Scholar
• D'Angio CT, Ryan RM. Animal models of bronchopulmonary dysplasia. The preterm and term rabbit models. Am J Physiol Lung Cell Mol Physiol 2014;307:L959–69
   PubMed Web of Science ®Google Scholar
• Albertine KH. Progress in understanding the pathogenesis of BPD using the baboon and sheep models. Semin Perinatol 2013;37:60–8
   PubMed Web of Science ®Google Scholar
• Yoder BA, Coalson JJ. Animal models of bronchopulmonary dysplasia. The preterm baboon models. Am J Physiol Lung Cell Mol Physiol 2014;307:L970–7
   PubMed Web of Science ®Google Scholar
• Shivanna B, Jiang W, Wang L, et al. Omeprazole attenuates hyperoxic lung injury in mice via aryl hydrocarbon receptor activation and is associated with increased expression of cytochrome P4501A enzymes. J Pharmacol Exp Ther 2011;339:106–14
   PubMed Web of Science ®Google Scholar
• Rehan VK, Sakurai R, Corral J, et al. Antenatally administered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury. Am J Physiol Lung Cell Mol Physiol 2010;299:L672–80
   PubMed Web of Science ®Google Scholar
• Couroucli XI, Liang YH, Jiang W, et al. Prenatal administration of the cytochrome P4501A inducer, Β-naphthoflavone (BNF), attenuates hyperoxic lung injury in newborn mice: implications for bronchopulmonary dysplasia (BPD) in premature infants. Toxicol Appl Pharmacol 2011;256:83–94
   PubMed Web of Science ®Google Scholar
• Warner BB, Stuart LA, Papes RA, Wispé JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998;275:L110–7
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264–9. W64
   PubMed Web of Science ®Google Scholar
• Macleod MR, Fisher M, O'Collins V, et al. Collaborative approach to meta analysis and review of animal data from experimental studies (CAMARADES). Edinburg: CAMARADES; 2011 Available from: http://www.dcn.ed.ac.uk/camarades/research.html#protocols [last accessed 10 Dec 2014]
   Google Scholar
• Leenaars M, Hooijmans CR, van Veggel N, et al. A step-by-step guide to systematically identify all relevant animal studies. Lab Anim 2012;46:24–31
   PubMed Web of Science ®Google Scholar
• Mandell E, Seedorf G, Gien J, Abman SH. Vitamin D treatment improves survival and infant lung structure after intra-amniotic endotoxin exposure in rats: potential role for the prevention of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2014;306:L420–8
   PubMed Web of Science ®Google Scholar
• Backstrom E, Lappalainen U, Bry K. Maternal IL-1beta production prevents lung injury in a mouse model of bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 2010;42:149–60
   PubMed Web of Science ®Google Scholar
• Goetzman BW, Read LC, Plopper CG, et al. Prenatal exposure to epidermal growth factor attenuates respiratory distress syndrome in rhesus infants. Pediatr Res 1994;35:30–6
   PubMed Web of Science ®Google Scholar
• Chen Y, Martinez MA, Frank L. Prenatal dexamethasone administration to premature rats exposed to prolonged hyperoxia: a new rat model of pulmonary fibrosis (bronchopulmonary dysplasia). J Pediatr 1997;130:409–16
   PubMed Web of Science ®Google Scholar
• Seidner SR, Jobe AH, Coalson JJ, Ikegami M. Abnormal surfactant metabolism and function in preterm ventilated baboons. Am J Respir Crit Care Med 1998;158:1982–9
   PubMed Web of Science ®Google Scholar
• Sosenko IR, Chen Y, Price LT, Frank L. Failure of premature rabbits to increase lung antioxidant enzyme activities after hyperoxic exposure: antioxidant enzyme gene expression and pharmacologic intervention with endotoxin and dexamethasone. Pediatr Res 1995;37:469–75
   PubMed Web of Science ®Google Scholar
• Frank L. Prenatal dexamethasone treatment improves survival of newborn rats during prolonged high O2 exposure. Pediatr Res 1992;32:215–21
   PubMed Web of Science ®Google Scholar
• Cosmi EV, Saitto C, Barbati A, et al. Effect of aminophylline on lung maturation in preterm rabbit fetuses. Am J Obstet Gynecol 1986;154:436–9
   PubMed Web of Science ®Google Scholar
• Ikegami M, Jobe AH, Pettenazzo A, et al. Effects of maternal treatment with corticosteroids, T3, TRH, and their combinations on lung function of ventilated preterm rabbits with and without surfactant treatments. Am Rev Respir Dis 1987;136:892–8
   PubMed Web of Science ®Google Scholar
• Ballard RA, Ballard PL, Bracken M, et al. Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. TRH Study Group. Lancet 1992;339:510–15
   PubMed Web of Science ®Google Scholar
• Crowther CA, Alfirevic Z, Haslam RR. Thyrotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev 2013;11:CD000019
   PubMedGoogle Scholar
• Anceschi MM, Petrelli A, Zaccardo G, et al. Inositol and glucocorticoid in the development of lung stability in male and female rabbit fetuses. Pediatr Res 1988;24:617–21
   PubMed Web of Science ®Google Scholar
• Wauer RR, Schmalisch G, Hammer H, et al. Ambroxol for prevention and treatment of hyaline membrane disease. Eur Respir J Suppl 1989;3:57S–65
   PubMedGoogle Scholar
• Gonzalez Garay AG, Reveiz L, Velasco Hidalgo L, Solis Galicia C, . Ambroxol for women at risk of preterm birth for preventing neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2014;10:CD009708
   PubMedGoogle Scholar
• Cosmi EV, La Torre R, Piazze JJ, et al. Intraamniotic surfactant for prevention of neonatal respiratory distress syndrome (IRDS): rationale and personal experience. Eur J Obstet Gynecol Reprod Biol 1997;71:135–9
   PubMed Web of Science ®Google Scholar
• Ostrzenski A, Radolinski B, Ostrzenska KM. Antenatal modes of surfactant administration for RDS prevention: a review. J Natl Med Assoc 2006;98:340–4
   PubMed Web of Science ®Google Scholar
• Bry K, Lappalainen U, Hallman M. Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J Clin Invest 1997;99:2992–9
   PubMed Web of Science ®Google Scholar
• Chen CM, Wang LF. High-dose vascular endothelial growth factor increases surfactant protein gene expressions in preterm rat lung. Early Hum Dev 2007;83:581–4
   PubMed Web of Science ®Google Scholar
• Debeer A, Sbragia L, Vrancken K, et al. Antenatal fetal VEGF therapy to promote pulmonary maturation in a preterm rabbit model. Early Hum Dev 2010;86:99–105
   PubMed Web of Science ®Google Scholar
• Strueby L, Thebaud B. Advances in bronchopulmonary dysplasia. Expert Rev Respir Med 2014;8:327–38
   PubMed Web of Science ®Google Scholar
• Jensen EA, Schmidt B. Epidemiology of bronchopulmonary dysplasia. Birth Defects Res Part A Clin Mol Teratol 2014;100:145–57
   PubMed Web of Science ®Google Scholar
• Eriksson L, Haglund B, Ewald U, et al. Short and long-term effects of antenatal corticosteroids assessed in a cohort of 7,827 children born preterm. Acta Obstet Gynecol Scand 2009;88:933–8
   PubMed Web of Science ®Google Scholar
• Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;CD004454
   Google Scholar
• Liu W, Purevdorj E, Zscheppang K, et al. ErbB4 regulates the timely progression of late fetal lung development. Biochim Biophys Acta 2010;1803:832–9
   PubMed Web of Science ®Google Scholar
• Purevdorj E, Zscheppang K, Hoymann HG, et al. ErbB4 deletion leads to changes in lung function and structure similar to bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2008;294:L516–22
   PubMed Web of Science ®Google Scholar
• Currie AE, Vyas JR, MacDonald J, et al. Epidermal growth factor in the lungs of infants developing chronic lung disease. Eur Respir J 2001;18:796–800
   PubMed Web of Science ®Google Scholar
• Romero R, Miranda J, Chaiworapongsa T, et al. Sterile intra-amniotic inflammation in asymptomatic patients with a sonographic short cervix: prevalence and clinical significance. J Matern Fetal Neonatal Med 2014;1–17
   Google Scholar
• Bhakta KY, Jiang W, Couroucli XI, et al. Regulation of cytochrome P4501A1 expression by hyperoxia in human lung cell lines: implications for hyperoxic lung injury. Toxicol Appl Pharmacol 2008;233:169–78
   PubMed Web of Science ®Google Scholar
• Lingappan K, Jiang W, Wang L, et al. Mice deficient in the gene for cytochrome P450 (CYP)1A1 are more susceptible than wild-type to hyperoxic lung injury: evidence for protective role of CYP1A1 against oxidative stress. Toxicol Sci 2014;141:68–77
   PubMed Web of Science ®Google Scholar
• Shivanna B, Zhang W, Jiang W, et al. Functional deficiency of aryl hydrocarbon receptor augments oxygen toxicity-induced alveolar simplification in newborn mice. Toxicol Appl Pharmacol 2013;267:209–17
   PubMed Web of Science ®Google Scholar
• Shivanna B, Chu C, Welty SE, et al. Omeprazole attenuates hyperoxic injury in H441 cells via the aryl hydrocarbon receptor. Free Radic Biol Med 2011;51:1910–17
   PubMed Web of Science ®Google Scholar
• Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary Dysplasia. N Engl J Med 1967;276:357–68
   PubMed Web of Science ®Google Scholar
• Bhandari A, Panitch HB. Pulmonary outcomes in bronchopulmonary dysplasia. Semin Perinatol 2006;30:219–26
   PubMed Web of Science ®Google Scholar
• Fawke J, Lum S, Kirkby J, et al. Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med 2010;182:237–45
   PubMed Web of Science ®Google Scholar
• Kotecha SJ, Edwards MO, Watkins WJ, et al. Effect of preterm birth on later FEV1: a systematic review and meta-analysis. Thorax 2013;68:760–6
   PubMed Web of Science ®Google Scholar
• Vom Hove M, Prenzel F, Uhlig HH, Robel-Tillig E. Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: a case-control follow-up at school age. J Pediatr 2014;164:40–5 e4
   PubMed Web of Science ®Google Scholar